Summary
creased. Chronic hyp&phenylalaninemia may state of subsensitivity of the pancreas for the insulin response to an acute phenylalanine load.
Phenylketonuria (PKU) due to phenylalanine hydroxylase deficiency is an inherited metabolic disorder characterized bv a defective conversion of phenylalanine to tyrosine. This enzyme is primarily found in the liver. In the untreated state, abnormally large concentrations of phenylalanine, phenylpyruvate, and other metabolites are present in blood and urine, whereas tyrosine levels are decreased. Although restriction in dietary phenylalanine can prevent the severe mental retardation which otherwise occurs, the mechanisms responsible for brain damage in this disease are not well understood. Phenylalanine is known to interfere with amino acid transport (29, 37) and to inhibit enzymes of the glycolytic pathway in brain (5, 14, 28, 39) . Phenylpyruvate, a phenylalanine metabolite, has been reported to inhibit pyruvate dehydrogenase (21, 24) , hepatic pyruvate carboxylase (36) , and brain fatty acid synthesis (22, 34) . Inhibition of pyruvate utilization could result in accumulation of pyruvate and lactate in the blood of phenylketonuric patients. In fact, greatly increased lactate and pyruvate levels have been reported in the blood and urine of individuals with PKU (24, 36) . Interest in carbohydrate metabolism in PKU has also been stimulated by reports of phenylalanine effects on insulin secretion (1 1, 12, 17, 30) on glucose transport (38) , on glucose metabolism (15, 16, 20) , and on pyruvate metabolism (28, 39) . In this study, we evaluated six retarded individuals with PKU on and off a low phenylalanine diet to further define the status of carbohydrate metabolism in PKU.
SUBJECTS
Six residents, 4 males and 2 females, of the Walter E. Fernald State School were selected from a group of 15 patients with PKU previously studied (35) . The diagnosis of PKU was based on the clinical features of mental retardation, hypopigmentation, and hyperactivity combined with an elevated serum phenylalanine level greater than 20 mg/dl. One subject received phenytoin to control seizures and continued on this medication throughout all phases of the study. Each participated in regular daily programs of moderate physical activity geared to their abilities. There was no family history of diabetes mellitus or other endocrinopathy. Their ages ranged from 19 to 53 (see Table 1 ). Informed consent was obtained from the guardians and families of each of the subjects participating in the study in accordance with United States Department of Health, Education, and Welfare and Commonwealth of Massachusetts Department of Mental Health regulations concerning human studies. These subjects served as their own controls off and on diet. In addition, three of the investigators served as normal controls.
METABOLIC DIETS
The subjects were fed the regular unrestricted high carbohydrate institutional diet or a low phenylalanine diet. None was on any other dietary restrictions at the beginning of the study. The low phenylalanine diet used during the second phase of the study was modeled after that used by the Boston Children's Hospital Medical Center Phenylketonuria Clinic. In this diet, allowable dietary protein and phenylalanine are calculated as follows: body weight (kg) x 15 mg phenylalanine per kg yields the maximum daily phenylalanine; body weight (kg) X 0.8 g protein/kg yields daily protein allowance. Daily protein allowance x 80% yields daily protein from Lofenalac (Mead, Johnson and Co.). This diet was supplemented with appropriate fruits, vegetables, and low phenylalanine bread and milk. Caloric intake was adjusted to maintain a stable weight. One patient received 375 mg and four received 500 mg total (7.8 to 11.4 mg/kg) of phenylalanine daily (50 to 75% of maximum allowable), an amount which maintained the serum phenylalanine value between 5 and 10 mg/dl. Specific flavorings were added to suit the taste of each individual subject. Their actual intake at each meal was monitored so that adjustments could be made that would ensure an adequate caloric intake. However, in spite of numerous modifications to the diet, subject 6 could not adjust to it and began losing weight. His phenylalanine level paradoxically increased from 20 to 40 mg/dl, presumably from skeletal muscle catabolism (see Table I ).
TOLERANCE TESTS
The subjects were evaluated with a series of tolerance tests during both the unrestricted and low phenylalanine dietary phases, so that the patients served as their own controls. Each dietary phase was maintained for at least 2 months before the start of these tests (26) . The challenges included a PO glucose tolerance test (1.75 g/kg) alone, PO phenylalanine alone (100 mglkg), and both simultaneously in combination (6, 7, 9) . All of these treatments followed an overnight fast and were ingested over a period of 5 min or less. Samples were obtained for glucose, insulin, pyruvate, lactate, and phenylalanine at 0, %, 1, 2, 3, and 4 hr. For the IV glucose challenge, 50% dextrose in water solution (0.5 &kg) was given as a bolus over a 5-min period. Samples were collected at 0, 5, 10, 20, 30,40, 50, 60, 120, 180, and 240 min. To minimize stress to the subject, an indwelling venous catheter was used at most times for blood sampling. Glucose was measured by a glucose oxidase technique (27) . In studies where glucose, pyruvate, and lactate were each assayed in the same specimens, their determinations were obtaified by enzymatic methods adapted to the spectrophotometer (25) . Phenylalanine and tyrosine were measured by a manual fluorometric assay (3, 4) . A double-antibody radioimmunoassay was used for quantitation of plasma insulin (19, 31, 40) and glucagon (2) .
RESULTS

SERUM PHENYLALANINE
Long-term monitoring of serum phenylalanine (Table 1) demonstrated that the low phenylalanine diet was effective in lowering the serum phenylalanine levels in subjects one to five from a range of 29 to 48 mg/dl before diet to values of 4.5 to 10.5 mg/dl while on the diet (26) . Lower levels were not attempted because hypoglycemia has been reported in phenylalanine-deficient diets (10) . Paradoxically, subject 6 demonstrated an increase from 20 to 40.5 mg/dl when the low phenylalanine diet was instituted.
SERUM GLUCOSE
Mean serum glucose levels are given in Table 2 . Fasting glucose levels for PKU subjects were approximately 90 to 100 mgldl (normal). There were no significant differences in serum glucose between subjects on and off the low phenylalanine diet when challenged with glucose alone, phenylalanine alone, or glucose plus phenylalanine. No consistent difference was noted for total glucose area (I) off or on a low phenylalanine diet in response to glucose challenge (Fig. 1A) .
PLASMA INSULIN
Plasma insulin values are shown in Table 2 . Fasting plasma insulin values for PKU subjects were approximately 10 pU/ml (normal). The mean peak plasma insulin level was observed one hr after a PO glucose load either given alone or in combination with phenylalanine. This peak response of insulin to glucose challenge alone reached a concentration of 73.5 f 30.7 pU/ml when off diet and 88.3 f 30.5 pU/ml when on diet (no significant difference). No consistent difference was noted for total insulin areas (I) after glucose challenge off or on the diet (Fig. IB) . The peak responses for a combined glucose and phenylalanine challenge were 92.7 f 38.4 and 91.0 It 30.2 pU/ml, off and on the low phenylalanine diet, respectively. Insulin response to PO gluwse loading was generally higher than by intravenous infusion (Fig. 2) .
'I'he subjects off diet showed little insulin response to PO phenylalanine ( Table 2 ). The same was true on diet except for one subject (subject 4) who had no response while off the diet, but did respond with an increase in plasma insulin when on diet. The plasma insulin values of this subject, along with those of three control subjects are shown in Figure 3 .
Glucagon assays were not routinely performed. Plasma glucagon in subject 4 rose as expected in response to phenylalanine loading while on the diet. Comparable values off the diet were not obtained.
BLOOD PYRUVATE AND LACTATE
The fasting levels of blood pyruvate (Table 3) were similar off (0.06 to 0.07 pmole/ml) and on (0.05 to 0.07 pmole/ml) the low phenylalanine diet. Pyruvate levels rose to a similar degree in response to PO glucose loading with a peak at one hr on the diet and at 2 hr when off the diet. Lactate levels rose in response to the PO glucose load both on and off the diet. The lactate response to the administration of PO phenylalanine in combination with glucose was similar to that of PO glucose alone.
DISCUSSION
Wapnir and Lifshitz (38) , in one well-studied case of a woman with PKU reported a slight impairment (-10.3%) in the small intestinal absorption of glucose which was not changed after treatment with a low phenylalanine diet. The mean values for the glucose tolerance tests of this group of PKU patients were normal. These data suggest that neither the blood level of phenylalanine nor the presence simultaneously of a phenylalanine load significantly affected the small intestinal absorption of glucose.
The relationship of phenylalanine to insulin and glucagon secretion and blood glucose levels is complex. Several amino acids including phenylalanine are known to stimulate insulin secretion in man (1 I, 12); and increased insulin sensitivity and intolerance to starvation have been reported in subjects with PKU (30). However, chronically increased phenylalanine levels do not raise basal levels of insulin or cause B-islet cell fatigue in the pancreas (18) and phenylalanine does not promote increased insulin secretion in the experimentally perfused rat pancreas (23) . Our studies confirm that baseline insulin levels are not significantly altered in PKU, but do indicate a lack of responsiveness to phenylalanine as an insulin secretagogue. The data from one subject suggest that this hyposensitivity to phenylalanine stimulation of insulin release may sometimes be reversible with diet.
Phenylalanine is also considered to be a gluconeogenic amino acid. An initial increase in the serum glucose level may be seen in normal subjects after phenylalanine loading (13) and a slight increase occurred in our patients both on a regular and low phenylalanine diet. This initial rise may be explained in part by CARBOHYDRATES M PKU 85 1 ' Subjects off diet had the regular institutional diet. Subjects on diet were given Lofenalac to lower the serum phenylalanine to a level of 5 to 10 mg/ dl. Patients were fasting overnight before the acute challenge with glucose (75 mdkg), phenylalanine (100 mg/kg), or combination of both (N = 6 off diet and 5 on diet). Mean f S.E. the conversion of phenylalanine to glucose and in part by an increase in glucagon secretion (17) . We have confirmed that PO phenylalanine loading stimulates glucagon secretion in one treated phenylketonuric patient. Further studies are needed to determine whether the glucagon stimulating effect of phenylalanine is diminished by chronic hyperphenylalanemia as seems to occur for its insulin secretagogic property. It seems plausible that hyposensitivity of the hormonal response to phenylalanine would develop in PKU patients on unrestricted diets. Otherwise, stimulation of insulin and glucagon release in PKU would be due primarily to this amino acid and the influence of other regulatory factors would be proportionately diminished.
GLUCOSE RESPONSE TO ORAL
In the present studies, we also administered glucose to challenge the pathways which produce and dispose of pyruvate. We found that basal levels of pyruvate and lactate in phenylketonuric subjects were normal, and only the expected modest increases in these levels occurred following glucose loading both off and on a low phenylalanine diet. These findings contrast with the observation of greatly elevated basal concentrations of pyruvate and lactate in 852 STEWART ET AL.
the blood of several patients with untreated PKU (36) and of increased amounts of pyruvate in the urine of a patient with untreated PKU (24) . The elevated pyruvate and lactate levels reported in three phenylketonuric (36) reactions by elevated phenylpyruvate. In these patients, the phenylalanine levels were 62, 68, and 38 mg/dl, values which were considerably higher than those of the subjects we studied. If phenylpyruvate levels were also higher in these patients, this may account for the differences between studies. It does not appear, however, that elevation of blood lactate and pyruvate levels is a general phenomenon in PKU patients.
Inhibition by phenylalanine of pyruvate kinase, an enzyme which catalyzes the conversion of phosphoenolpyruvate to pyruvate, has been shown to occur in brain both in vitro (39) and in vivo (28) . In rat liver and brain, phenylalanine competitively inhibits pyruvate kinase and leads to an increase in the intermediates of glywlysis from fructose-1, 6-diphosphate to phosphoenolpyruvate and to a decrease in pyruvate (14) . Our results show that any inhibition of pyruvate kinase by phenylalanine was insufficient to prevent the normal rise in blood lactate and pyruvate after a gluwse load.
Both on theoretical grounds and experimentally, it would appear that phenylalanine has a complex relationship with carbohydrate metabolism, especially when this amino acid is present in excess, as in PKU. It is possible that abnormalities in glucose uptake and utilization at the cellular level contribute to the pathogenesis of the brain disorder in untreated phenylketonuric infants. Major alterations in the parameters of carbohydrate metabolism after a glucose load were not observed in the blood, a fluid which predominantly reflects carbohydrate metabolism in liver and muscle. The absence of an increased insulin secretion following acute phenylalanine loading in the PKU patients suggests that chronic hyperphenylalaninemia blunts the insulinogenic response to acute phenylalanine stimulation. ' Bloods were collected by venipuncture and immediately mixed with 1 N perchloric acid and frozen in dry ice until processed. After thawing and centrifugation at 15,000 X g, the supernatants were neutralized with KOH and assayed for glucose, lactate, and pyruvate.
Mean S.E. for the three subjects studied on and off the low phenylalanine diet following feeding of glucose, phenylalanine, or both at time 0.
Significance at the 5% level in the comparison with patients on the diet receiving glucose alone, by Student's t test. Only the two other conditions in which glucose was administered are compared and not the condition when phenylalanine alone was given.
